To Keep Your Heart Healthy, Try Drinking More Orange Juice

Translate to Spanish or other 102 languages!

Orange juice dampened — or downregulated — hypertension (high blood pressure) genes. Hypertension can lead to stroke, heart attacks, and heart failure. Image for illustration purposes
Orange juice dampened — or downregulated — hypertension (high blood pressure) genes. Hypertension can lead to stroke, heart attacks, and heart failure. Image for illustration purposes
- Advertisement -

Medical News Today

Orange juice dampened — or downregulated — hypertension (high blood pressure) genes. Hypertension can lead to strokeheart attacks, and heart failure.

It did the same for inflammatory genes. Inflammation can lead to cardiac events by constricting and damaging blood vessels, as well as promoting the formation of dangerous plaque buildup.

- Advertisement -

At the same time, orange juice upregulated – promoted – the activity of genes responsible for metabolizing fat, helping the body process and store it more efficiently.

Follow the link below to read he full story on Medical News Today:

https://www.medicalnewstoday.com/articles/orange-juice-could-help-support-heart-health

Information source: https://www.medicalnewstoday.com

- Advertisement -

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

How Dogs Benefit Mind and Soul

"Dogs are wonderful greeters. They're waiting for you to come home, and they're always happy to see you. In turn, this increases our feel-good hormones, like dopamine and serotonin,” explained Chivonna Childs, PhD.

Data Reveals US Illicit Fentanyl Use is Double That of Clinical Care

The largest study to date that quantifies and compares medical and illegal use of fentanyl in the United States suggests that illicit use is more than twice as common as medically based use. 

7 Crucial Caregiving Truths Families Often Overlook

If you clicked to read this story, or someone sent it to you, congratulations: You’re a caregiver.

Moderna and Merck Report Positive Phase 3 Results for Personalized Cancer Therapy

Moderna and Merck have reached a major clinical milestone after their investigational individualized cancer therapy, combined with Merck’s Keytruda, produced positive results in a Phase 3 study involving patients with high-risk melanoma.
- Advertisement -